Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new treatment for scars to see if it is safe and effective.
- Keloid
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is it still possible for individuals to participate in the trial?
"Affirmative. According to clinicaltrials.gov, this research study is currently enrolling participants and was initially posted on June 23rd 2021. The most recent update occurred on May 11th 2022 and 30 people need to be recruited from 1 medical facility."
Are mature individuals eligible to partake in this research?
"This study only accepts patients between the ages of 18-60. However, there are other trials available for minors (161 studies) and seniors (920 studies)."
What criteria need to be met for someone to qualify as a participant of this research project?
"In order to be part of this research, subjects must have keloid scarring and lie in the age range 18-60. The total number of participants required is 30 individuals."
Could you tell me what the uppermost limit of participants is for this clinical trial?
"Affirmative. Information available on clinicaltrials.gov indicates that this research project, which was published initially on June 23rd 2021, is actively recruiting participants . 30 patients are required to partake in the trial at 1 medical centre."
What deleterious effects can be incurred by taking AIV001?
"Owing to the fact this is a Phase 1 trial, and there is therefore limited information on AIV001's efficacy or safety, our team has assigned it a score of 1."
Share this study with friends
Copy Link
Messenger